Cerity Partners LLC Boosts Stock Position in Cigna Group $CI

Cerity Partners LLC lifted its holdings in Cigna Group (NYSE:CI) by 157.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 234,668 shares of the health services provider’s stock after purchasing an additional 143,568 shares during the quarter. Cerity Partners LLC’s holdings in Cigna Group were worth $64,587,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of CI. Norges Bank bought a new stake in Cigna Group in the fourth quarter worth $1,019,790,000. Northwestern Mutual Wealth Management Co. lifted its position in Cigna Group by 13,333.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after buying an additional 3,141,844 shares during the last quarter. Capital Research Global Investors lifted its position in Cigna Group by 140.2% in the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after buying an additional 1,855,897 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its position in Cigna Group by 8.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after buying an additional 903,334 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its position in Cigna Group by 54.5% in the third quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock worth $615,781,000 after buying an additional 753,865 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Price Performance

Shares of CI stock opened at $294.77 on Wednesday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The firm has a market capitalization of $77.97 billion, a price-to-earnings ratio of 12.50, a PEG ratio of 1.12 and a beta of 0.28. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. The stock’s 50-day simple moving average is $280.60 and its 200-day simple moving average is $277.57.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. During the same quarter in the previous year, the firm earned $6.74 earnings per share. The company’s revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. The ex-dividend date is Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s payout ratio is presently 26.45%.

Insider Buying and Selling at Cigna Group

In other news, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Truist Financial raised their price target on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. The Goldman Sachs Group raised their price target on Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Jefferies Financial Group decreased their target price on Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their target price for the stock from $310.00 to $304.00 in a research report on Tuesday, May 26th. Finally, Raymond James Financial set a $340.00 price target on Cigna Group in a research note on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Cigna Group has an average rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.